Publications

Detailed Information

Impact of glycemic control on the progression of aortic stenosis: a single-center cohort study using a common data model

DC Field Value Language
dc.contributor.authorHwang, In-Chang-
dc.contributor.authorKim, Seok-
dc.contributor.authorBoo, Dachung-
dc.contributor.authorPark, Changhyun-
dc.contributor.authorYoo, Sooyoung-
dc.contributor.authorYoon, Yeonyee E.-
dc.contributor.authorCho, Goo-Yeong-
dc.date.accessioned2023-08-11T01:40:48Z-
dc.date.available2023-08-11T10:41:40Z-
dc.date.issued2023-07-10-
dc.identifier.citationBMC Endocrine Disorders Vol.23(1):143ko_KR
dc.identifier.issn1472-6823-
dc.identifier.urihttps://hdl.handle.net/10371/195346-
dc.description.abstractBackground
Diabetes mellitus (DM) is a well-established risk factor for the progression of degenerative aortic stenosis (AS). However, no study has investigated the impact of glycemic control on the rate of AS progression. We aimed to assess the association between the degree of glycemic control and the AS progression, using an electronic health record-based common data model (CDM).

Methods
We identified patients with mild AS (aortic valve [AV] maximal velocity [Vpeak] 2.0–3.0 m/sec) or moderate AS (Vpeak 3.0–4.0 m/sec) at baseline, and follow-up echocardiography performed at an interval of ≥ 6 months, using the CDM of a tertiary hospital database. Patients were divided into 3 groups: no DM (n = 1,027), well-controlled DM (mean glycated hemoglobin [HbA1c] < 7.0% during the study period; n = 193), and poorly controlled DM (mean HbA1c ≥ 7.0% during the study period; n = 144). The primary outcome was the AS progression rate, calculated as the annualized change in the Vpeak (△Vpeak/year).

Results
Among the total study population (n = 1,364), the median age was 74 (IQR 65–80) years, 47% were male, the median HbA1c was 6.1% (IQR 5.6–6.9), and the median Vpeak was 2.5 m/sec (IQR 2.2–2.9). During follow-up (median 18.4 months), 16.1% of the 1,031 patients with mild AS at baseline progressed to moderate AS, and 1.8% progressed to severe AS. Among the 333 patients with moderate AS, 36.3% progressed to severe AS. The mean HbA1c level during follow-up showed a positive relationship with the AS progression rate (β = 2.620; 95% confidence interval [CI] 0.732–4.507; p = 0.007); a 1%-unit increase in HbA1c was associated with a 27% higher risk of accelerated AS progression defined as △Vpeak/year values > 0.2 m/sec/year (adjusted OR = 1.267 per 1%-unit increase in HbA1c; 95% CI 1.106–1.453; p < 0.001), and HbA1c ≥ 7.0% was significantly associated with an accelerated AS progression (adjusted odds ratio = 1.524; 95% CI 1.010–2.285; p = 0.043). This association between the degree of glycemic control and AS progression rate was observed regardless of the baseline AS severity.

Conclusion
In patients with mild to moderate AS, the presence of DM, as well as the degree of glycemic control, is significantly associated with accelerated AS progression.
ko_KR
dc.language.isoenko_KR
dc.publisherBMCko_KR
dc.subjectAortic stenosis-
dc.subjectDiabetes mellitus-
dc.subjectGlycemic control-
dc.titleImpact of glycemic control on the progression of aortic stenosis: a single-center cohort study using a common data modelko_KR
dc.typeArticleko_KR
dc.identifier.doi10.1186/s12902-023-01403-5ko_KR
dc.citation.journaltitleBMC Endocrine Disordersko_KR
dc.language.rfc3066en-
dc.rights.holderThe Author(s)-
dc.date.updated2023-07-16T03:11:06Z-
dc.citation.number1ko_KR
dc.citation.volume23ko_KR
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share